The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells

Frontiers in Cardiovascular Medicine - Tập 8
Y Soma1, Yuika Morita1, Yoshikazu Kishino1, Hideaki Kanazawa1, Keiichi Fukuda1, Shugo Tohyama1
1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan

Tóm tắt

The number of patients with heart failure (HF) is increasing with aging in our society worldwide. Patients with HF who are resistant to medication and device therapy are candidates for heart transplantation (HT). However, the shortage of donor hearts is a serious issue. As an alternative to HT, cardiac regenerative therapy using human pluripotent stem cells (hPSCs), such as human embryonic stem cells and induced pluripotent stem cells, is expected to be realized. Differentiation of hPSCs into cardiomyocytes (CMs) is facilitated by mimicking normal heart development. To prevent tumorigenesis after transplantation, it is important to eliminate non-CMs, including residual hPSCs, and select only CMs. Among many CM selection systems, metabolic selection based on the differences in metabolism between CMs and non-CMs is favorable in terms of cost and efficacy. Large-scale culture systems have been developed because a large number of hPSC-derived CMs (hPSC-CMs) are required for transplantation in clinical settings. In large animal models, hPSC-CMs transplanted into the myocardium improved cardiac function in a myocardial infarction model. Although post-transplantation arrhythmia and immune rejection remain problems, their mechanisms and solutions are under investigation. In this manner, the problems of cardiac regenerative therapy are being solved individually. Thus, cardiac regenerative therapy with hPSC-CMs is expected to become a safe and effective treatment for HF in the near future. In this review, we describe previous studies related to hPSC-CMs and discuss the future perspectives of cardiac regenerative therapy using hPSC-CMs.

Từ khóa


Tài liệu tham khảo

2020, The Registry Report of Japanese Heart Transplantation-2020, Ishoku, 55, 261, 10.11386/jst.55.3_261

Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science., 282, 1145, 10.1126/science.282.5391.1145

Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell., 126, 663, 10.1016/j.cell.2006.07.024

Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell., 131, 861, 10.1016/j.cell.2007.11.019

Murry, 2006, Regeneration gaps: observations on stem cells and cardiac repair, J Am Coll Cardiol., 47, 1777, 10.1016/j.jacc.2006.02.002

Nakamura, 2003, A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis, Proc Natl Acad Sci USA., 100, 5834, 10.1073/pnas.0935626100

Ladd, 1998, Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins, Dev Biol., 204, 407, 10.1006/dbio.1998.9094

Naito, 2006, Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis, Proc Natl Acad Sci USA., 103, 19812, 10.1073/pnas.0605768103

Ueno, 2007, Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells, Proc Natl Acad Sci USA., 104, 9685, 10.1073/pnas.0702859104

Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nat Biotechnol., 25, 1015, 10.1038/nbt1327

Lian, 2012, Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling, Proc Natl Acad Sci USA., 109, E1848, 10.1073/pnas.1200250109

Hentze, 2009, Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies, Stem Cell Res., 2, 198, 10.1016/j.scr.2009.02.002

Fong, 2009, Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS), Stem Cell Rev Rep., 5, 72, 10.1007/s12015-009-9054-4

Tang, 2011, An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells, Nat Biotechnol., 29, 829, 10.1038/nbt.1947

Wang, 2011, Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis, Cell Res., 21, 1551, 10.1038/cr.2011.148

Dubois, 2011, SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells, Nat Biotechnol., 29, 1011, 10.1038/nbt.2005

Hattori, 2010, Nongenetic method for purifying stem cell-derived cardiomyocytes, Nat Methods., 7, 61, 10.1038/nmeth.1403

Kuang, 2017, Efficient, selective removal of human pluripotent stem cells via ecto-alkaline phosphatase-mediated aggregation of synthetic peptides, Cell Chem Biol., 24, 685, 10.1016/j.chembiol.2017.04.010

Lee, 2013, Inhibition of pluripotent stem cell-derived teratoma formation by small molecules, Proc Natl Acad Sci USA., 110, E3281, 10.1073/pnas.1303669110

Tateno, 2015, Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein, Stem Cell Rep., 4, 811, 10.1016/j.stemcr.2015.02.016

Ben-David, 2013, Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells, Nat Commun., 4, 1992, 10.1038/ncomms2992

Tohyama, 2013, Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes, Cell Stem Cell., 12, 127, 10.1016/j.stem.2012.09.013

Tohyama, 2016, Glutamine oxidation is indispensable for survival of human pluripotent stem cells, Cell Metab., 23, 663, 10.1016/j.cmet.2016.03.001

Shiraki, 2014, Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells, Cell Metab., 19, 780, 10.1016/j.cmet.2014.03.017

Ben-David, 2013, Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen, Cell Stem Cell., 12, 167, 10.1016/j.stem.2012.11.015

Tanosaki, 2020, Fatty acid synthesis is indispensable for survival of human pluripotent stem cells, iScience., 23, 101535, 10.1016/j.isci.2020.101535

Okada, 2019, Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3, Biochem Biophys Res Commun., 511, 711, 10.1016/j.bbrc.2019.02.094

Parr, 2016, MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells, Sci Rep., 6, 32532, 10.1038/srep32532

Chen, 2015, Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells, Stem Cell Res., 15, 365, 10.1016/j.scr.2015.08.002

Kempf, 2014, Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture, Stem Cell Rep., 3, 1132, 10.1016/j.stemcr.2014.09.017

Fonoudi, 2015, A universal and robust integrated platform for the scalable production of human cardiomyocytes from pluripotent stem cells, Stem Cells Transl Med., 4, 1482, 10.5966/sctm.2014-0275

Halloin, 2019, Continuous WNT control enables advanced hPSC cardiac processing and prognostic surface marker identification in chemically defined suspension culture, Stem Cell Rep., 13, 366, 10.1016/j.stemcr.2019.06.004

Ting, 2014, An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures, Stem Cell Res., 13, 202, 10.1016/j.scr.2014.06.002

Ting, 2018, Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess, Stem Cell Res., 31, 161, 10.1016/j.scr.2018.07.020

Tohyama, 2017, Efficient large-scale 2D culture system for human induced pluripotent stem cells and differentiated cardiomyocytes, Stem Cell Rep., 9, 1406, 10.1016/j.stemcr.2017.08.025

Rupert, 2020, Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques, PLoS ONE., 15, e0230001, 10.1371/journal.pone.0230001

Tohyama, 2017, Safe and effective cardiac regenerative therapy with human-induced pluripotent stem cells: how should we prepare pure cardiac myocytes?, Circ Res., 120, 1558, 10.1161/CIRCRESAHA.116.310328

Lopaschuk, 2010, Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation, J Cardiovasc Pharmacol., 56, 130, 10.1097/FJC.0b013e3181e74a14

Sugiura, 2016, Visualization of in vivo metabolic flows reveals accelerated utilization of glucose and lactate in penumbra of ischemic heart, Sci Rep., 6, 32361, 10.1038/srep32361

Olivetti, 1990, Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats, Circ Res., 67, 23, 10.1161/01.RES.67.1.23

Caulfield, 1976, The relationship of myocardial infarct size and prognosis, Circulation., 53, I141

Hemmi, 2014, A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes, Stem Cells Transl Med., 3, 1473, 10.5966/sctm.2014-0072

Miyazaki, 2008, Recombinant human laminin isoforms can support the undifferentiated growth of human embryonic stem cells, Biochem Biophys Res Commun., 375, 27, 10.1016/j.bbrc.2008.07.111

Chen, 2011, Chemically defined conditions for human iPSC derivation and culture, Nat Methods., 8, 424, 10.1038/nmeth.1593

Klim, 2010, A defined glycosaminoglycan-binding substratum for human pluripotent stem cells, Nat Methods., 7, 989, 10.1038/nmeth.1532

Melkoumian, 2010, Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells, Nat Biotechnol., 28, 606, 10.1038/nbt.1629

Someya, 2021, Tryptophan metabolism regulates proliferative capacity of human pluripotent stem cells, iScience., 24, 102090, 10.1016/j.isci.2021.102090

Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation., 126, S29, 10.1161/CIRCULATIONAHA.111.084343

Gerbin, 2015, Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts, PLoS ONE., 10, e0131446, 10.1371/journal.pone.0131446

Higuchi, 2015, Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart, Cell Transplant., 24, 2479, 10.3727/096368914X685799

Li, 2017, Human pluripotent stem cell-derived cardiac tissue-like constructs for repairing the infarcted myocardium, Stem Cell Rep., 9, 1546, 10.1016/j.stemcr.2017.09.007

Weinberger, 2016, Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells, Sci Transl Med., 8, 363ra148, 10.1126/scitranslmed.aaf8781

Querdel, 2021, Human engineered heart tissue patches remuscularize the injured heart in a dose-dependent manner, Circulation., 143, 1991, 10.1161/CIRCULATIONAHA.120.047904

Suzuki, 2021, Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model, J Heart Lung Transplant., 40, 767, 10.1016/j.healun.2021.04.010

Shiba, 2012, Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts, Nature., 489, 322, 10.1038/nature11317

Chong, 2014, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts, Nature., 510, 273, 10.1038/nature13233

Shiba, 2016, Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts, Nature., 538, 388, 10.1038/nature19815

Liu, 2018, Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates, Nat Biotechnol., 36, 597, 10.1038/nbt.4162

Kawaguchi, 2021, Intramyocardial transplantation of human iPS cell-derived cardiac spheroids improves cardiac function in heart failure animals, JACC Basic Transl Sci., 6, 239, 10.1016/j.jacbts.2020.11.017

Cho, 2017, Neonatal transplantation confers maturation of PSC-derived cardiomyocytes conducive to modeling cardiomyopathy, Cell Rep., 18, 571, 10.1016/j.celrep.2016.12.040

Kadota, 2017, In vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts, Stem Cell Reports., 8, 278, 10.1016/j.stemcr.2016.10.009

Romagnuolo, 2019, Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias, Stem Cell Rep., 12, 967, 10.1016/j.stemcr.2019.04.005

Hattan, 2005, Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice, Cardiovasc Res., 65, 334, 10.1016/j.cardiores.2004.10.004

Nakajima, 2015, Gelatin hydrogel enhances the engraftment of transplanted cardiomyocytes and angiogenesis to ameliorate cardiac function after myocardial infarction, PLoS ONE., 10, e0133308, 10.1371/journal.pone.0133308

Lee, 2018, Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix, Nat Biomed Eng., 2, 104, 10.1038/s41551-018-0191-4

Tabei, 2019, Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell–derived cardiomyocytes, J Heart Lung Transplant., 38, 203, 10.1016/j.healun.2018.11.002

Park, 2019, Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following myocardial infarction, Nat Commun., 10, 3123, 10.1038/s41467-019-11091-2

Bargehr, 2019, Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration, Nat Biotechnol., 37, 895, 10.1038/s41587-019-0197-9

Sun, 2020, Transplanted microvessels improve pluripotent stem cell-derived cardiomyocyte engraftment and cardiac function after infarction in rats, Sci Transl Med., 12, eaax2992, 10.1126/scitranslmed.aax2992

Funakoshi, 2021, Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells, Nat Commun., 12, 3155, 10.1038/s41467-021-23329-z

Perin, 2012, Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial, JAMA., 307, 1717, 10.1001/jama.2012.418

Traverse, 2012, Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial, JAMA., 308, 2380, 10.1001/jama.2012.28726

Nakamura, 2021, Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes, Stem Cell Reports, 16, 2473, 10.1016/j.stemcr.2021.08.005

Karbassi, 2020, Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine, Nat Rev Cardiol., 17, 341, 10.1038/s41569-019-0331-x

Lu, 2013, Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin, Stem Cell Rev Rep., 9, 806, 10.1007/s12015-013-9457-0

Deuse, 2019, Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients, Nat Biotechnol., 37, 252, 10.1038/s41587-019-0016-3

Xu, 2019, Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility, Cell Stem Cell., 24, 566, 10.1016/j.stem.2019.02.005

Menasché, 2015, Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report, Eur Heart J., 36, 2011, 10.1093/eurheartj/ehv189

Thông tin
Thông tin xuất bản

Frontiers in Cardiovascular Medicine

Tập 8

Thông tin tác giả